WEKO3
アイテム
{"_buckets": {"deposit": "999c3c7f-bc40-4894-9053-1575a949caa8"}, "_deposit": {"id": "18116", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "18116"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00018116", "sets": ["456", "1129"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Pathophysiological Heterogeneity of Disseminated Intravascular Coagulation (DIC)"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1996-05", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "5", "bibliographicPageEnd": "165", "bibliographicPageStart": "161", "bibliographicVolumeNumber": "110", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "In disseminated intravascular coagulation (DIC), clinical and laboratory manifestations are extremely variable among patients, depending in most part on the underlying diseases. Patients with DIC caused by leukemia and vascular lesions show marked activation of fibrinolysis, resulting in the predominant bleeding tendency. In addition to the synthesis of procoagulant tissue factor, leukemic cells, especially acute promyelocytic leukemia cells, produce and secrete profibrinolytic plasminogen activators and leukocyte proteases, which would contribute to the excessive fibrinolysis seen in these patients. Patients with sepsis show relatively suppressed fibrinolysis and are frequently complicated by organ damage. Endotoxin, TNF and IL-1 stimulate the synthesis of tissue factor and plasminogen activator inhibitor-1, and decrease the expression of thrombomodulin and heparan sulfate in endothelial cells, which result in the predominant activation of coagulation and suppression of fibrinolysis. Intermediate profiles are observed in patients with solid cancer and malignant lymphoma. Since the pathogenesis and hemostatic profiles are thus variable among patients with DIC, management should be individualized for each patient.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "113663", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Takahashi, Hoyu"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "高橋, 芳右"}], "nameIdentifiers": [{"nameIdentifier": "113662", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-08"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "110(5)_161-165.pdf", "filesize": [{"value": "1.3 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1300000.0, "url": {"label": "110(5)_161-165.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/18116/files/110(5)_161-165.pdf"}, "version_id": "bb5f6c56-bcc7-4103-8a1e-9047153887b9"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "balance of activation of blood coagulation and fibrinolysis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "DIC with predominant fibrinolysis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "DIC with relatively suppressed fibrinolysis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "sepsis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "leukemia", "subitem_subject_scheme": "Other"}, {"subitem_subject": "凝固・線溶活性化バランス", "subitem_subject_scheme": "Other"}, {"subitem_subject": "線溶亢進型・出血型 DIC", "subitem_subject_scheme": "Other"}, {"subitem_subject": "線溶抑制型・臓器障害型 DIC", "subitem_subject_scheme": "Other"}, {"subitem_subject": "敗血症", "subitem_subject_scheme": "Other"}, {"subitem_subject": "白血病", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "DICの病態の多様性", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "DICの病態の多様性"}, {"subitem_title": "DICの病態の多様性", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1129"], "permalink_uri": "http://hdl.handle.net/10191/43051", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-08-04"}, "publish_date": "2016-08-04", "publish_status": "0", "recid": "18116", "relation": {}, "relation_version_is_last": true, "title": ["DICの病態の多様性"], "weko_shared_id": null}
DICの病態の多様性
http://hdl.handle.net/10191/43051
http://hdl.handle.net/10191/43051d5b85ef8-7318-4768-9396-361b8723a2fd
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2016-08-04 | |||||
タイトル | ||||||
タイトル | DICの病態の多様性 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | DICの病態の多様性 | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | balance of activation of blood coagulation and fibrinolysis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | DIC with predominant fibrinolysis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | DIC with relatively suppressed fibrinolysis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | sepsis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | leukemia | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 凝固・線溶活性化バランス | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 線溶亢進型・出血型 DIC | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 線溶抑制型・臓器障害型 DIC | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 敗血症 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 白血病 | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | Pathophysiological Heterogeneity of Disseminated Intravascular Coagulation (DIC) | |||||
著者 |
高橋, 芳右
× 高橋, 芳右 |
|||||
著者別名 | ||||||
識別子 | 113663 | |||||
識別子Scheme | WEKO | |||||
姓名 | Takahashi, Hoyu | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | In disseminated intravascular coagulation (DIC), clinical and laboratory manifestations are extremely variable among patients, depending in most part on the underlying diseases. Patients with DIC caused by leukemia and vascular lesions show marked activation of fibrinolysis, resulting in the predominant bleeding tendency. In addition to the synthesis of procoagulant tissue factor, leukemic cells, especially acute promyelocytic leukemia cells, produce and secrete profibrinolytic plasminogen activators and leukocyte proteases, which would contribute to the excessive fibrinolysis seen in these patients. Patients with sepsis show relatively suppressed fibrinolysis and are frequently complicated by organ damage. Endotoxin, TNF and IL-1 stimulate the synthesis of tissue factor and plasminogen activator inhibitor-1, and decrease the expression of thrombomodulin and heparan sulfate in endothelial cells, which result in the predominant activation of coagulation and suppression of fibrinolysis. Intermediate profiles are observed in patients with solid cancer and malignant lymphoma. Since the pathogenesis and hemostatic profiles are thus variable among patients with DIC, management should be individualized for each patient. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 110, 号 5, p. 161-165, 発行日 1996-05 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
著者版フラグ | ||||||
値 | publisher |